A genetic test known as chromosomal microarray analysis (CMA) could help identify the cause of sudden infant death syndrome (SIDS) or its counterpart in older children, known as sudden unexplained ...
A genetic test known as chromosomal microarray analysis (CMA) could help identify the cause of sudden infant death syndrome (SIDS) or its counterpart in older children, known as sudden unexplained ...
Molecular testing, including chromosomal microarray analysis, distinguishes between aggressive and indolent kidney cancer subtypes, aiding in accurate diagnosis. Accurate diagnosis is critical for ...
Researchers have identified pathogenic gene variations in 12% of cases of sudden unexplained death in children. The new study, which involved 116 cases of sudden infant death syndrome (SIDS) or sudden ...
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Variantyx, a leader in genomic precision medicine, today announced the launch of its IriSight™ CNV Analysis - a whole genome-based test for the detection of ...
Would you want to know if your unborn baby is at risk of autism? Researchers wrapping up a 4,406-patient study say that a new genetic test that analyzes fetal DNA in more detail than current prenatal ...
The newly proposed workflow has 93% success rate compared to 9.6% success rate of traditional methods by eliminating cell culture, replacing karyotyping analysis with OGM for comprehensive SV analysis ...
Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results